ARCHIVES

Program Monitors Resistance In Antimicrobial And Antifungal Therapies for Cancer Patients

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

Herberman: Progress Made To Stabilize NSABP

September 9, 1994

Brothers Of Prostate Cancer Patients At Risk Of Diagnosis

August 27, 2010

Editorial: A Record-Breaking Year for The Cancer Letter

December 19, 2014

DCT Counselors Ponder Coordination, New Opportunities

December 12, 1975

NSABP Disputed NCI Cost Estimate For P-4 Trial.

May 25, 2007

NCI-Approved Trials Listed

March 30, 2007